NIH-Led Studies Point to Potential Development of a Cataract Drug
Researchers at the National Institutes of Health (NIH) and their collaborators have identified a protein, known as RNF114, that reverses cataracts, a clouding of the eye’s lens that occurs commonly in people as they age.
18-Sep-2024 11:05 AM EDT
Add to Favorites